June 24, 2025
ACHP calls on Congress to increase access to biosimilars by redefining interchangeability requirements and addressing outdated regulations, skewed incentives and PBM practices that intentionally slow their adoption.
Loading...
Loading...
Reload document 
Open in new tab 
